CIK 0000744218
- Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133191702
- Phone
- +1 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-10 | Martin Samuel Bates SVP and CFO | Sale | −2,056 | $45.25 | $93K | 18,981 |
| 2021-08-10 | Martin Samuel Bates SVP and CFO | Sale | −682 | $45.25 | $31K | 29,378 |
| 2020-12-14 | Wright Richard M. Sr. VP & CCO | Sale | −11,457 | $18.61 | $213K | 208 |
| 2020-12-14 | Wright Richard M. Sr. VP & CCO | Sale | −9,375 | $18.61 | $174K | 208 |
Page 3 of 3 · 44 trades